An internationally mobile family may arrange an appointment in London, an assessment in Switzerland, and follow-up in Dubai. That is access. Whether clinicians share the relevant history and agree on responsibilities is another question. The evidence does not show that international care is inherently worse. It shows why continuity should be planned rather than assumed.
Key findings
21 or more nights versus 1 to 6 nights a month: the business-travel comparison in a study published in 2018.
2.27: the prevalence ratio for mild-or-worse depressive symptoms in the higher-travel group.
1.69 and 1.37: corresponding ratios for anxiety symptoms and trouble sleeping.
2.04: the ratio for a positive alcohol-problem screen.
17 studies and around 300,000 patients: a separate 2023 review of relational continuity in serious mental illness.
The travel findings are historical associations, not proof of causation or estimates for HNW expatriates. The continuity review concerns a different population. [1] [3]
Extensive travel was associated with several symptom measures
Source: Rundle and colleagues. A ratio is not an absolute probability for an individual. The comparison does not identify every trip as international rather than domestic. [1]
| Outcome | Prevalence ratio | 95% confidence interval |
|---|---|---|
| Trouble sleeping | 1.37 | 1.09 to 1.71 |
| Mild-or-worse anxiety symptoms | 1.69 | 1.29 to 2.21 |
| Mild-or-worse depressive symptoms | 2.27 | 1.70 to 3.03 |
| Positive alcohol-problem screen | 2.04 | 1.26 to 3.29 |
These are symptom and screening measures, not confirmed diagnoses. The study used a corporate-wellness sample rather than a representative survey of international families. [1]
The study is not a prediction for every frequent traveler
People who travel extensively can differ in their work, responsibilities, and other circumstances. A cross-sectional comparison cannot establish which factors caused the pattern or whether symptoms preceded the schedule. The calendar alone cannot diagnose someone.
The historical date matters too. The study is not a measurement of postpandemic travel in 2026. Its value is to motivate better questions about individual circumstances and contemporary research, not establish a universal limit on nights away.
A person traveling less should not assume that the result rules out a problem. As with any group comparison, the pattern does not replace assessment when someone reports concerns.
Travel guidance puts preparation before reassurance
The CDC’s 2026 Yellow Book chapter, published in April 2025, notes limited population-level evidence on mental health problems in travelers. It recommends considering clinical history, treatment continuity, and access to appropriate support before travel. Medication availability and requirements differ between countries. [2]
A premium insurance policy or well-connected adviser should not be assumed to resolve every issue after arrival. The relevant arrangements need to be established before the person relies on them. This is individual preparation, not a blanket argument against travel.
The clinical history, destination, duration, and treatment needs matter more than a broad label such as expatriate. The plan should address the specific situation rather than a stereotype about globally mobile people.
Continuity has more than one meaning
Information continuity means the next clinician has the relevant history. Management continuity means the plan remains coherent between professionals. Relational continuity concerns an ongoing therapeutic relationship. A family may have one without the others.
A complete record can be transferred while responsibility for the next review remains unclear. A trusted therapist can remain involved while medication is managed elsewhere without sufficient communication. The first step is identifying the particular gap, not assuming that more appointments will solve it.
Specialization can be valuable. Coordination does not mean one clinician should perform every task. It means the patient understands who is responsible for each part and how those parts fit together.
What the continuity review found
The December 2023 review covered 17 studies and around 300,000 patients with serious mental illness. Greater relational continuity was associated with potentially better mortality, emergency-attendance, and quality-of-life outcomes. Evidence certainty was low or very low, and substantial differences prevented a pooled effect estimate. [3]
The review could not draw reliable conclusions for several other outcomes, including costs and symptom functioning. Its population is not the same as affluent families arranging private international care. It supports attention to continuity without proving a quantified benefit from a particular concierge service.
A provider should distinguish that clinical rationale from its own measured results. It should not borrow a percentage from an unrelated study and present it as the effect of its administrative coordination.
A wider choice creates a responsibility question
Several specialist opinions can be useful, especially when the clinical picture is complex. Someone still needs to explain how recommendations are compared. The family should not have to reconcile conflicting instructions through reputation or seniority alone.
A coordinating role should have explicit limits. It should identify when another specialist leads and how changes are communicated. The goal is coherent advice, not centralization for administrative convenience.
That clarity should begin before a new treatment setting is selected. Asking who will manage the transition later is not an afterthought when the person expects to return to another country.
A handover should be a completed process
| Stage | What should be clear | Evidence of completion |
|---|---|---|
| Before departure | Formulation, treatment, and concerns | Agreed summary and named professionals |
| Receiving care | Who can provide the required review? | Confirmed acceptance |
| Information | What is shared with consent? | Relevant records received securely |
| Follow-up | Who reviews progress and change? | Scheduled review and contact route |
| Urgent needs | Which local service is appropriate? | Clear local emergency plan |
A discharge letter is not proof that another service accepted responsibility. A contact list is not an appointment, and a file transfer is not confirmation of clinical review. Each step should be described accurately.
This framework is a proposal, not a scorecard certifying a particular service. Its purpose is to make the transition inspectable without promising that paperwork alone produces better outcomes.
Country differences should be checked, not improvised
The UK, United States, Germany, Switzerland, Netherlands, and GCC do not share one system. Prescriptions, remote consultations, and insurance arrangements should not be assumed valid everywhere because they worked where care began. Relevant clinicians, authorities, and insurers need to confirm applicable requirements.
The same applies during a crisis. A planned overseas provider may not be the right immediate destination. Access to international care should not delay urgent local assessment when someone is acutely unwell.
Cultural fit requires an individual conversation
The CDC chapter recognizes that finding culturally compatible care can be difficult for long-term travelers. A person may prefer a particular language or someone familiar with their context. That should prompt a discussion of preferences, not assumptions about everyone from a country. [2]
Shared background is not a substitute for relevant clinical expertise. Technical expertise does not eliminate the need for effective communication either. The service should explain how fit is assessed and what happens when the initial match is not helpful.
Evaluate the pathway without inventing an outcome
A coordinator can measure completed handovers, record availability, and appointments attended. Those processes are useful, but do not establish recovery. Clinical outcomes need their own measures and follow-up.
Reports should record additional care and missing observations. When several services contribute, improvement should not be attributed entirely to the organization that arranged the first contact. A future study could examine the contribution more rigorously with defined participants and appropriate consent.
Compare completed arrangements, not promises
A practical review can ask whether the receiving clinician has accepted the referral, whether relevant records arrived, and whether the patient knows the next appointment. These are observable steps, not a guarantee of recovery. They help distinguish a proposed transition from one that actually occurred.
The patient should also know what happens when the plan changes. Travel delays, a different residence, or a revised clinical recommendation may require a new arrangement. Clear responsibility matters more than the number of names on the original contact list.
For a family choosing an international service, this is a concrete comparison to request before paying. It preserves the value of choice while asking whether the pathway remains usable after the first treatment episode.
What the numbers cannot tell us
The travel study does not prove causation or estimate HNW expatriate prevalence. The continuity review does not validate a private coordination model. No cross-border treatment-failure rate, country ranking, or THE BALANCE patient outcome is calculated.
The bottom line
Mobility should not make responsibility disappear. The advantage of access to several countries should be a coherent pathway, not merely a longer contact list. The quality of the handover deserves as much attention as the reputation of the first appointment.
For journalists
Key finding: extensive business travel was associated with higher symptom and screening prevalence in the historical employee study.
Important caveat: the figures are not current diagnostic rates or proof that travel caused illness.
Suggested attribution: THE BALANCE analysis of business-travel research and continuity-of-care evidence.
Methodology and sources
This narrative analysis separates a cross-sectional travel study, current-edition guidance, and a continuity review. Ratios retain their intervals and comparator. No findings are pooled into an international treatment effect.
